Therapy Areas
Publix suspends administration of Johnson & Johnson COVID-19 vaccine based on CDC and FDA guidance
14 April 2021 -

Grocery business Publix said on Tuesday that its is suspending the administration of the Johnson & Johnson COVID-19 vaccine at all of its pharmacy locations following guidance from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA).

The CDC and FDA have issued a joint media statement with additional information about the Johnson & Johnson COVID-19 vaccine.

While a rare side effect, individuals who have received the Johnson & Johnson COVID-19 vaccine should contact their health care provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks, according to the CDC and FDA.

However, the customers can visit to schedule an appointment for the Moderna COVID-19 vaccine, if currently available in their state.



Related Headlines